Cardiovascular
-
AngioDynamics Acquires BioSentry Sealant; Provides Update on Bard Antitrust Lawsuit
Enhancements made to its Oncology business; favorable U.S. District Court ruling impacts its Vascular Access business.AngioDynamics 08.15.18
-
Cardiovascular | Patient Monitoring
FDA OKs BioSig's Pure EP System for Electrophysiology
PURE EP acquires, digitizes, amplifies, filters, measures & calculates, displays, records & stores ECG/intracardiac signals.GlobeNewswire 08.14.18
-
Cardiovascular | Neurological
First FDA-Approved Study of Focused Ultrasound to Open Blood-Brain Barrier
Brain's protective network of blood vessels impedes cancer-fighting drugs from reaching tumors.Videos University of Maryland Medical Center
-
Cardiovascular | Neurological | Surgical | Testing
Active Implantable Medical Device Testing: What You Need to Know
Both the implanted product and non-implantable supporting equipment require testing and evaluation to specific standards.Online Exclusives William Stearns, Associate Senior Engineer, Intertek 08.13.18
-
Cardiovascular
CorWave Issued U.S. Patent Covering its Implantable Left Ventricular Assist Device
Company is protecting its wave membrane technology designs for pumping blood.CorWave 08.13.18
-
Cardiovascular
Gore Announces First In-Human Use of GORE TAG Conformable Thoracic Stent Graft
New delivery system provides controlled, predictable placement of highly conformable and time-tested stent graft.Business Wire 08.10.18
-
Cardiovascular
FDA Approves Zephyr Endobronchial Valve for Treating Severe Emphysema
Device for emphysema proven to help patients breathe easier and enjoy more active lives.Business Wire 08.10.18
-
Cardiovascular
CHLA/USC Researchers Design Novel Micropacemaker
The researchers team up to design and implant a minimally-invasive device in area around the heart.Business Wire 08.09.18
-
Cardiovascular
Endologix Reports Positive One-Year Results from the Ovation LUCY Study
Data show that women had similar outcomes to men after treatment with the ultra-low profile Ovation device.Business Wire 08.09.18
-
Cardiovascular
Medtronic Begins Pilot Study of Investigational Extravascular ICD System
Study evaluating new ICD system designed to deliver pacing and defibrillation therapy via a lead placed under the sternum.Globe Newswire 08.09.18
-
Cardiovascular | Surgical
Boston Scientific to Acquire VENITI for $108M
Acquisition to bolster company's Venous Therapies portfolio within Peripheral Interventions Division.PR Newswire 08.08.18
-
Cardiovascular
iRhythm Technologies Names Chief Operating Officer
New executive brings more than 20 years of experience to the position.Globe Newswire 08.08.18
-
Cardiovascular | Neurological
Integrated Sensor Could Monitor Brain Aneurysm Treatment
Highly stretchable, hyper-elastic flow diverter uses a highly-porous thin film nitinol.Georgia Institute of Technology 08.07.18
-
Cardiovascular
Lexington Biosciences Concludes Initial HeartSentry Clinical Study
Company prepares for multicenter pivotal clinical study.Globe Newswire 08.07.18
-
Cardiovascular
Avinger Announces Successful Treatment of First Patients with Next-Generation Pantheris
The product’s design includes a simplified single balloon system for cutter apposition and blood flow management.Globe Newswire 08.06.18
-
Cardiovascular | Surgical
BD Appoints Exec. VP & President of Interventional Segment
Since the completion of the Bard transaction, Simon Campion has been serving as worldwide president of the Surgery business.PR Newswire 08.01.18
-
Cardiovascular
FEops Strengthens Management Team
Company adds two former Abbott executives to its management team.Business Wire 08.01.18
-
Cardiovascular
JenaValve Technology Implants Initial Patients With Next-Generation TAVR System
Enrollment yields successful implantation with Everdur Transcatheter Valve.Business Wire 08.01.18
-
Cardiovascular
FDA OKs Medtronic's SynchroMed II Pump with Remodulin to Treat Hypertension
SynchroMed II drug delivery system and cardiac catheter technologies were leveraged to deliver Remodulin.Medtronic 07.31.18
-
Cardiovascular | Surgical
Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System
Investigational Tendyne device is first and only repositionable and fully retrievable mitral valve replacement.Abbott Laboratories 07.27.18
